Polymeric cups for cavitation mediated delivery of oncolytic vaccinia virus

Polymeric cups for cavitation mediated delivery of oncolytic vaccinia virus

Oncolytic viruses (OV) could become the most powerful and selective cancer therapies. However, the limited transport of OV into and throughout tumors following intravenous injection means their clinical administration is often restricted to direct intratumoral dosing. Application of physical stimuli...

Full description

Bibliographic Details
Main Authors:	Myers, R, Coviello, C, Erbs, P, Foloppe, J, Rowe, C, Kwan, J, Crake, C, Finn, S, Jackson, E, Balloul, J, Story, C, Coussios, C, Carlisle, R
Format:	Journal article
Published:	Nature Publishing Group 2016

Similar Items

Ultrasound-mediated cavitation does not decrease the activity of small molecule, antibody or viral-based medicines
by: Myers, R, et al.
Published: (2018)

Ultrasound-mediated cavitation does not decrease the activity of small molecule, antibody or viral-based medicines
by: Myers R, et al.
Published: (2018-01-01)

Enhancement and passive acoustic mapping of cavitation from fluorescently tagged magnetic resonance-visible magnetic microbubbles in vivo.
by: Crake, C, et al.
Published: (2016)

Cavitation-enhanced delivery of a self-amplifying oncolytic adenovirus for tumour-selective cancer therapy.
by: Carlisle, R, et al.
Published: (2012)

Improved therapeutic antibody delivery to xenograft tumors using cavitation nucleated by gas-entrapping nanoparticles
by: Grundy, M, et al.
Published: (2021)

Safety studies and viral shedding of intramuscular administration of oncolytic vaccinia virus TG6002 in healthy beagle dogs
by: Jérémy Béguin, et al.
Published: (2020-08-01)

Polymer stealthing and mucin-1 retargeting for enhanced pharmacokinetics of an oncolytic vaccinia virus
by: Hill, C, et al.
Published: (2021)

Cavitation-enhanced delivery of a replicating oncolytic adenovirus to tumors using focused ultrasound.
by: Bazan-Peregrino, M, et al.
Published: (2013)

Oncolytic virotherapy with intratumoral injection of vaccinia virus TG6002 and 5-fluorocytosine administration in dogs with malignant tumors
by: Jérémy Béguin, et al.
Published: (2023-09-01)

Safety, biodistribution and viral shedding of oncolytic vaccinia virus TG6002 administered intravenously in healthy beagle dogs
by: Jérémy Béguin, et al.
Published: (2021-01-01)

Fluorescent Tagged Vaccinia Virus Genome Allows Rapid and Efficient Measurement of Oncolytic Potential and Discovery of Oncolytic Modulators
by: Franck Gallardo, et al.
Published: (2020-11-01)

Vaccinia Virus Shuffling: deVV5, a Novel Chimeric Poxvirus with Improved Oncolytic Potency
by: Marine Ricordel, et al.
Published: (2018-07-01)

Preclinical Evaluation of the Oncolytic Vaccinia Virus TG6002 by Translational Research on Canine Breast Cancer
by: Jérémy Béguin, et al.
Published: (2020-12-01)

Polymer stealthing and mucin-1 retargeting for enhanced pharmacokinetics of an oncolytic vaccinia virus
by: Claudia Hill, et al.
Published: (2021-06-01)

The Enhanced Tumor Specificity of TG6002, an Armed Oncolytic Vaccinia Virus Deleted in Two Genes Involved in Nucleotide Metabolism
by: Johann Foloppe, et al.
Published: (2019-09-01)

Exploitation of sub-micron cavitation nuclei to enhance ultrasound-mediated transdermal transport and penetration of vaccines
by: Bhatnagar, S, et al.
Published: (2016)

Use of micro- and nano-sized inertial cavitation nuclei to trigger and map drug release from cavitation-sensitive liposomes.
by: Graham, S, et al.
Published: (2013)

Inertial cavitation at the nanoscale.
by: Kwan, J, et al.
Published: (2013)

Inertial cavitation at the nanoscale
by: Kwan, J, et al.
Published: (2013)

Cavitation-mediated immunomodulation and its use with checkpoint inhibitors
by: Maardalen, M, et al.
Published: (2023)

Investigation of strategies to enhance the delivery of oncolytic vaccinia virus
by: Hill, C
Published: (2020)

High Oncolytic Activity of a Double-Deleted Vaccinia Virus Copenhagen Strain against Malignant Pleural Mesothelioma
by: Tiphaine Delaunay, et al.
Published: (2020-09-01)

Ultrasound-induced cavitation enhances the delivery and therapeutic efficacy of an oncolytic virus in an in vitro model.
by: Bazan-Peregrino, M, et al.
Published: (2012)

Ultrasound-induced cavitation enhances the delivery and therapeutic efficacy of an oncolytic virus in an in vitro model
by: Bazan-Peregrino, M, et al.
Published: (2012)

Theranostic Potential of Oncolytic Vaccinia Virus
by: Juan J Rojas, Steve H Thorne
Published: (2012-01-01)

Oncolytic vaccinia virus and cancer immunotherapy
by: Lihua Xu, et al.
Published: (2024-01-01)

Robust Capon beamforming for passive cavitation mapping during high-intensity focused ultrasound therapy.
by: Coviello, C, et al.
Published: (2010)

Real-time three-dimensional passive cavitation detection for clinical high intensity focussed ultrasound systems
by: Collin, J, et al.
Published: (2013)

Real-time three-dimensional passive cavitation detection for clinical high intensity focused ultrasound systems.
by: Collin, J, et al.
Published: (2013)

Immunotherapeutic Potential of Oncolytic Vaccinia Virus
by: Stephen eThorne
Published: (2014-06-01)

Oncolytic vaccinia therapy of squamous cell carcinoma
by: Yu Yong A, et al.
Published: (2009-07-01)

Oncolytic Vaccinia Virus in Lung Cancer Vaccines
by: Cao-Sang Truong, et al.
Published: (2022-02-01)

Achieving systemic delivery of oncolytic viruses
by: Hill, C, et al.
Published: (2019)

Ultrasound-enhanced delivery of polymer-coated oncolytic adenovirus for tumour growth inhibition
by: Carlisle, R, et al.
Published: (2011)

Data for Enhancement and passive acoustic mapping of cavitation from fluorescently-tagged MR-visible magnetic microbubbles in vivo
by: Crake, C
Published: (2016)

Recent progress in combination therapy of oncolytic vaccinia virus
by: Seyedeh Nasim Mirbahari, et al.
Published: (2024-03-01)

Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
by: Zong Sheng Guo, et al.
Published: (2019-01-01)

Correlation of cavitation with ultrasound enhancement of thrombolysis.
by: Datta, S, et al.
Published: (2006)

Inertial cavitation to non-invasively trigger and monitor intratumoral release of drug from intravenously delivered liposomes.
by: Graham, S, et al.
Published: (2014)

Cavitation-Mediated Immunomodulation and Its Use with Checkpoint Inhibitors
by: Matilde Maardalen, et al.
Published: (2023-08-01)